Table 3.
Prognostic factors | Cox hazard model | ||
HR | 95% CI | P value | |
Tumor stage (recurrent after surgery and stage VI/recurrent-after chemoradiotherapy) | 5.00 | 0.64 to 39.06 | 0.125 |
Performance status (2–3/0–1) | 3.18 | 1.35 to 7.51 | 0.008 |
PD-L1 expression (50%–100%/0%–49%) | 1.24 | 0.56 to 2.78 | 0.596 |
Monocyte (median) | 0.64 | 0.29 to 1.40 | 0.264 |
Neutrophil:lymphocyte ratio (median) | 2.17 | 0.75 to 6.25 | 0.151 |
Albumin (median) | 1.59 | 0.68 to 3.69 | 0.283 |
Multivariate model (median) | 3.55 | 1.47 to 8.59 | 0.005 |
Each prognostic factor for overall survival was evaluated by multivariate Cox proportional hazard analysis.